2024 International Congress Archives - Page 83 of 181

Gut Microbiota May Alter Glucose Metabolism in Patients with Parkinson’s Disease

ST. Tsai, MK. Lu, CH. Tsai, Y. Aoh, ZL. Lai, YY. Hsu, DS. Chao, PR. Hsueh (Taichung, Taiwan)
Habenular Structural Connectivity Changes in Parkinson’s Disease: A 7T MRI Study

B. Samanci, A. Bayram, S. Tan, M. Wanders, M. Kuijf, Y. Temel (Maastricht, Netherlands)
Hand and Arm Function in Persons with De Novo Parkinson’s Disease

B. Lindholm, LB. Dahlin, CH. Brogårdh, E. Franzen (Malmö, Sweden)
Handwriting Features in Patients with Isolated REM Sleep Behaviour Disorder

R. Torricelli, J. Kenny, E. Bache, L. Pérez-Carbonell, B. Huxford, H. Chohan, G. Leschziner, A. Lees, A. Schrag, A. Noyce, C. Simonet (London, United Kingdom)
Haptics’ use in extended reality environments for Parkinson disease: A systematic review

L. Ali, C. Lella, G. Giuliano, R. Di Fuccio (Napoli, Italy)
Harnessing chaperone-mediated autophagy through viral-based LAMP2A overexpression in non-human primates as a Treatment of Parkinson’s Disease

ML. Arotcarena, M. Fouka, E. Gialinaki, L. Stefanis, E. Bezard, M. Xilouri, B. Dehay (BORDEAUX, France)
Health Care Utilization at the End-Of-Life in Parkinson´s Disease

B. Leavy, E. åkesson, J. Lökk, T. Schultz, P. Strang, E. Franzén (Stockholm, Sweden)
Hemiparkinsonism Induction with 6-OHDA in Primates Does Not Induce SN Hyperechogenicity.

L. Krejcova, W. Quaresma, L. Pedrosa, L. Leal, J. Muniz, B. Gomes (Belem, Brazil)
Hemochromatosis and Movement Disorders

P J. Garcia Ruiz, C. Garcia Campos, C. Feliz, J. Del Val, J. Montoya (Torrelodones, Spain)
Hesperidin lessens rotenone induced Parkinson diseases angiogenesis in nigrostriatal neuronal death through the AMPK/FOXO3 Signaling pathway

DS. Singh (Allahabad, India)